Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Dec 11;15(12):e0243278. doi: 10.1371/journal.pone.0243278

Life satisfaction and happiness in patients shielding from the COVID-19 global pandemic: A randomised controlled study of the ‘mood as information’ theory

Alice O’Donnell 1, Lydia Wilson 1, Jos A Bosch 2, Richard Borrows 3,*
Editor: Itamar Ashkenazi4
PMCID: PMC7732102  PMID: 33306679

Abstract

Objectives

To extrapolate the ‘mood as information’ theory to the unique and ecologically relevant setting of the COVID-19 pandemic; the specific aim was to inform health care providers of the impact of bringing the pandemic to salience during life satisfaction evaluations, assessing whether this ‘prime’ results in increased or decreased reports of satisfaction which are derived unconsciously.

Design

Prospective Randomised Interventional Study.

Setting

Renal Transplant Department in a tertiary centre in the United Kingdom.

Participants

200 Renal transplant patients aged between 20 and 88 years. Telephone interviews were undertaken between 1st May, 2020 and 29th May, 2020, at the height of ‘shielding’ from COVID-19.

Interventions

Participants were randomised into 2 groups, with 1 group receiving a simple ‘priming question’ regarding the COVID pandemic and the other group having no prior contact.

Main outcome measurements

Individuals were then asked to rate their own overall lifetime happiness; desire to change; overall life satisfaction and momentary happiness on a scale of 1 to 10 for each measure. Independent sample t-tests were used to compare results between the two groups, with a type 1 error rate below 5% considered statistically significant.

Results

Participants’ overall happiness with their life as a whole revealed that individuals who were primed with a question about COVID-19 reported increased overall happiness with their life compared to individuals who had not been primed (+0.88, 95% confidence interval 0.42 to 1.35, p = 0.0002). In addition, participants in the primed group reported less desire to change their life when compared to the non-primed group (-1.35, 95% confidence interval -2.06 to -0.65, p = 0.0002). Participants who were primed with the COVID-19 question also reported a higher overall satisfaction with their life than individuals who had not been primed (+1.01, 95% confidence interval 0.50 to 1.52, p = 0.0001). Finally, the participants who received the priming question demonstrated increased reported momentary happiness (+0.64, 95% confidence interval 0.03 to 1.24, p = 0.04).

Conclusions

The results demonstrated that bringing salience to the COVID-19 pandemic with a simple question leads to positive changes in both momentary happiness and other components of global life satisfaction, thereby extrapolating evidence for the application of the mood-as-information theory to more extreme life circumstances. Given the importance of patient-reported evaluations, these findings have implications for how, when and where accurate and reproducible measurements of life satisfaction should be obtained.

Introduction

The global coronavirus pandemic of 2019/2020 (‘COVID-19’) represents a thankfully rare, yet hugely salient event that had a negative impact on multiple aspects of people’s lives across the world. This has particularly been the case for patients advised to undertake an extreme form of social isolation known as ‘shielding’, because of actual or perceived risk of disease severity. It became clear early in the pandemic, for example, that renal transplant patients should be included in the high-risk group [1], and were advised by the UK Department of Health to shield from COVID-19. Whilst appropriate on many levels, this unpleasant circumstance is likely to negatively impact upon life satisfaction and is inevitably accompanied by feelings of isolation, loneliness and frustration [2].

Life satisfaction and happiness are determined not only by overall personal dispositions and life-events, but also by momentary circumstances. In a landmark study—colloquially known as the ‘weather’ experiment—Schwarz and Clore identified the influence of such momentary circumstances on the judgement of individuals’ lives more globally (in terms of satisfaction and happiness), and that this may occur outside a subject’s awareness [3]. Specifically, these authors undertook telephone calls, asking participants for their subjective opinions on life satisfaction and happiness. The simple, but intriguing randomisation process involved asking participants: “how is the weather with you?” prior to the core life satisfaction questions. When the momentary mood-effect of poor weather (but not, in contrast, good weather) was made salient in this way, the negative effect of momentary mood on the judgement of one’s life was removed (a so-called ‘discounting effect”) [4]. The theoretical implications of this finding are twofold. Firstly, the study offered the ‘mood as information’ theory (also known as ‘affect as information’ theory) which predicts that transient alterations in mood also changes how individuals evaluate their life circumstances more globally. Secondly, by bringing plausible causes of negative mood (such as poor weather) into the awareness of the individual, the participants were provided with information they may use to attribute any negative feelings, allowing them to ‘discount’ the effect of their momentary mood on global judgement of life satisfaction [5, 6].

It is reasonable to suggest that such attributional and discounting effects could be extrapolated from weather to other scenarios. Specifically, the COVID-19 pandemic provides a unique example of a profound negative affective prime. We were, therefore, interested to evaluate its effects on life satisfaction and happiness in our renal transplant recipients undertaking ‘mandatory’ shielding, as an extreme model of the social isolation practices undertaken by many individuals across the world. This represented an opportunity to explore whether the above theoretical considerations and experimental findings may have real-life implications. If a patient’s evaluation of satisfaction with their quality of life is to guide rational clinical decision-making, then understanding how and when such evaluations can be influenced by random circumstantial factors (that the patient is unaware of) becomes an important component of this strategy.

We utilised methodology derived from the Schwarz and Clore’s (1983) study, described above, conducting telephone interviews with patients shielding at the height of the UK epidemic [3]. These patients were randomised to either receive or not receive, a simple priming question about the COVID-19 pandemic before answering questions about their life satisfaction. Based on extant theory, the use of this COVID-19 priming question could plausibly result in two mutually exclusive results. On one hand, raising awareness of the pandemic may bring attention to patients’ negative situations, resulting in lower scores for overall life satisfaction [7]. Alternatively, the priming question may allow participants to attribute their mood to the negative external circumstance, and such explanatory discounting will yield higher scores for the subsequent life satisfaction questions.

Interestingly, and perhaps somewhat counter-intuitively, but nevertheless in agreement with the aforementioned ‘weather study’, our study demonstrated the latter hypothesis to be valid.

Materials and methods participants

Two hundred-and-nineteen kidney transplant patients who were actively shielding from COVID-19 were invited to participate in the study, 19 of whom declined. Participants were recruited to this study from the renal transplant clinic at the Queen Elizabeth Hospital Birmingham, a large tertiary hospital serving the urban population of the UKs second largest city in which rates of COVID-19 were second only to London for the duration of the study. Specifically, and as part of a wider response to COVID-19 by medical students of the University of Birmingham, a student support worker was tasked with coordinating the uninterrupted supply of life-preserving immunosuppression medications to a number of prevalent renal transplant recipients. This was undertaken universally by telephone conversations. Once the clinical aspects of their care were discharged, patients were asked if they would be willing to participate in the study to evaluate their life satisfaction and wellbeing via a short telephone conversation the following week. The study was then undertaken between 1st and 29th May, 2020. To put this in perspective, these transplant patients (along with other vulnerable groups) received letters advising to shield on 21st March 2020; the UK was placed into ‘lockdown’ on 23rd March and easing of restrictions began on 6th July. Patients were advised to cautiously cease shielding from July 31st 2020.

The study was approved by the local clinical audit and research department of the Queen Elizabeth Hospital. In light of the circumstances, methodology and lack of identifiable patient-level information in the results, consent was implied by participation in the study, obtained verbally, and the requirement for signed consent was waived. The study was exempt from clinical trials registration on the basis it sought to inform providers’ knowledge and attitudes, rather than influence or inform patients’ health or behaviours. Patients were free to drop out of (or decline) the study at any time, and a minimum of 7 days elapsed between requesting participation and the subsequent telephone study itself, allowing time for full consideration regarding participation.

Study design and data collection

Patient randomisation was undertaken using a random number generator which separated those to be primed with a question about the COVID-19 pandemic (n = 114), and those who were not (n = 86).

All participants were then asked the same 4 questions about their life satisfaction (see below) and their results recorded accordingly. The scripted conversation used the following introduction: “Hello, I’m ___ from the Queen Elizabeth Hospital. We spoke last week about a project we are doing within the renal transplant department about patients’ life satisfaction and mood. Are you still willing to participate?”

For those agreeing to continue with the study (n = 200) at that point, patients in the ‘primed’ (‘experimental’) group (n = 114), were asked: “By the way, how’s the COVID-19 pandemic making you feel at the moment?” The researcher did not engage in conversation in regard to this; rather, after the participant responded, the researcher replied with: “Well, let’s get back to the research—we are interested in our patients’ life satisfaction and mood as it is very important to us. Would you be able to answer 4 brief questions for us?” In the non-primed group (n = 86), the interviewer continued after the standard opening, without the question about the COVID-19 pandemic.

Following the appropriate introduction, participants were asked the following 4 questions, taken verbatim from the original ‘weather’ experiment described above and asked in the same order.

  1. “First, on a scale of 1 to 10, with 10 being the happiest, how happy do you feel about your life as a whole?”

  2. “Thinking of how your life is going now, how much would you like to change your life from what it is now? This is also on a scale of 1 to 10. Ten means "change a very great deal" and one "means not at all."”

  3. “All things considered, how satisfied or dissatisfied are you with your life as a whole these days, with number 10 being the most satisfied.”

  4. “And, how happy do you feel at this moment? Again, 10 is the happiest.”

The interviewer then concluded the telephone call with: “That's all the questions I have. Thank you for your time and cooperation”.

Following the telephone call, patients’ demographic and clinical data were retrieved from the departmental database and hospital electronic results system. The latest results prior to the lockdown period were recorded for analysis.

Statistical analysis

All responses were integers between 1 and 10. Statistical Analysis was performed using GraphPad. Results were presented as mean ± standard deviation (SD). Independent sample t-tests were used to compare results between the two groups, with a type 1 error rate below 5% considered statistically significant.

Ethical approval

Protocol for this project was approved by the relevant CARMS committee (clinical audit and research) at the Queen Elizabeth Hospital.

Results

The characteristics of the studied population are shown in Table 1. No differences in routine demographics or transplant-related metrics were evident between groups, with the characteristics typical of a prevalent renal transplant population. Specifically, Table 1 shows results for key parameters related to the transplant status and renal history which could conceivably be tied to life satisfaction and mood. Other routine biochemical and haematological data, evaluated for the last set of laboratory tests prior to the lockdown period, was also compared between groups, and no differences found.

Table 1. Summary of participant demographics.

COVID-19 primed group Non-COVID-19 primed group
(n = 114) (n = 86)
Mean age (SD1) 54.0 (12.3) 54.2 (12.3)
Gender (Male) 68/114 (59.6%) 50/86 (58.1%)
Race:
White 84/114 (73.7%) 63/86 (73.2%)
South Asian 24/114 (21.0%) 20/86 (23.2%)
African-Caribbean 6/114 (5.3%) 3/86 (3.5%)
Time on dialysis prior to transplant (IQR2) 31 (2–70) months 29 (2–71) months
Diabetes:
Pre-transplant 13/114 (11.4%) 10/86 (11.6%)
PTDM 3 17/114 (14.9%) 14/86 (16.3%)
Live Donor Transplant Recipient 20/114 (17.5%) 17/86 (19.8%)
Time Post Transplant (IQR) 52 (22–122) months 51 (20–123) months
Prior Acute Rejection4 17/114 (14.9%) 15/86 (17.4%)
Last eGFR5 prior to shielding (SD) 45 (18) ml/min 46 (17) ml/min
Tacrolimus versus non-Tacrolimus based immunosuppression6 85/114 (74.6%) 67/86 (77.9%)
Body Mass Index (SD) 27.9 (5.6) kg/m2 28.2 (5.7) kg/m2

1: Standard Deviation (parametric data)

2: Interquartile range (non-parametric data)

3: Post Transplant Diabetes Mellitus

4: Acute transplant rejection was diagnosed by transplant biopsy in all cases; any episode at any time post-transplant (irrespective of histological or clinical classification) was captured

5: Estimated Glomerular Filtration Rate

6: Most ‘non-Tacrolimus’ treated patients received ciclosporin. A minority of patients were treated with either sirolimus or no calcineurin inhibitor at all (total n = 6 across both arms of study)

The mean time from the start of the shielding period to the interview with participants was 51.5 ± 8.5 days, and the mean time from the interview till the end of the shielding period was 74.5 ± 8.5 days.

A summary of the results of the 4 questions in the primed and no-primed groups can be seen in Fig 1, with the full set of data shown in the S1 Data. The answers to all questions across the groups were normally distributed. Differences observed between the two groups in overall happiness (t198 = 3.77; p = 0.0002), desire to change (t198 = 3.78; p = 0.0002), satisfaction with life as a whole (t198 = 3.93; p = 0.0001) and happiness in this moment (t198 = 2.08; p = 0.04) were all significant.

Fig 1. Graphical representation of the results from Table 1, showing the mean reported scores with standard deviation bars.

Fig 1

Discussion

The study is predicated on the basis that humans desire explanations for behaviours, thoughts and feelings. The mood-as-information theory predicts that knowledge of what influences one’s momentary feelings (moods) is used to evaluate and re-evaluate other judgements about one’s life. The present study sought to evaluate the influence of momentary mood upon global life satisfaction and overall happiness in the ‘unique’ setting of a viral pandemic among people (kidney transplant recipients) who underwent shielding. Asking patients a question about this negative event, was predicted to be utilised as an explanation for their mood, resulting in a discounting effect whereby ‘momentary happiness’ is used to explain, and adjust for judgements about overall happiness and satisfaction with life. In keeping with this, the results showed that bringing salience to the COVID-19 pandemic (with a simple question) results in positive changes in both momentary happiness and other components of global life satisfaction, thereby extrapolating evidence for the mood-as-information theory to these more extreme life circumstances with realistic ecological validity. Our observations refute the equally plausible prediction that bringing negative circumstances into awareness would prime or facilitate other negative evaluations, at least when the source of negative mood can be attributed ‘externally’ (see discussion below).

As mentioned in the introduction, this (mis)attribution phenomenon seems to be unidirectional; attribution of negative events will improve low mood, but the converse does not occur [8]. Indeed, it has been suggested this may represent a mechanism by which humans maintain a state of ‘positive mood offset’, which in turn promotes varied and coordinated cognitions in general [9]. Our findings do indeed resonate with this notion, although we propose that two other assumptions require attention before accepting the mechanism described above. Firstly, that the affective stimulus is a negative one. In this regard, Schwarz and Clore assumed that adverse weather represented a negative affective stimulus, and we consider that an assumption that the COVID-19 pandemic should be considered similarly is a reasonable one. Although at the time of writing, relatively little data has been released, emerging evidence does suggest a negative affective response to COVID-19 [10]. There has been unprecedented disruption of lives and work; health, distress and life satisfaction of working adults in China one month into the COVID-19 outbreak and further information will emerge as the pandemic progresses [11]. Secondly, to produce the results of the current study, negative affect requires attribution ‘externally’ and ‘impersonally’, that is to say they are attributed to the situation rather than the dispositional characteristics of the individual. In the face of negative events, people displaying a ‘healthy’ attributional style will also consider the events ‘temporary’ (i.e. not a permanent feature of their life moving forward), and not ‘pervasive’ (i.e. not representative of all facets of life) [12]. In summary, this style of attribution will result in unconscious processing along the lines of, “COVID-19 is a negative event for me, but not about me; won’t be permanent and won’t impact on every facet of my life”. Assessment of attributional style was beyond the scope and logistics of the current study, and it is certainly possible that the cohort included patients with more pessimistic styles whereby events are characterised to be ‘personal’, ‘permanent’ and ‘pervasive’. On the basis of the aggregate results, however, it would seem that the cohort as a whole displayed a broadly healthy/optimistic style of attribution. It is relevant in this regard to contrast the current results (and also those of Schwarz and Clore) with those of authors such as Strack et al (1988) who used a similar methodology but asked participants about their dating experiences before self-evaluation of life satisfaction [3, 6]. On this occasion, no effect of bringing relationship success into consciousness was seen, in all probability because relationship success will likely be regarded as ‘personal’, ‘permanent’, and ‘pervasive’, and therefore unamenable to external attribution. Participants in that study are likely to have viewed (from a psychological perspective) this information as a ‘negative’ prime in regard to overall life satisfaction, rather than as a source of explanation.

The results may have important clinical implications. In light of contemporary recognition of the importance of patient-reported evaluations, realisation that individuals’ overall life satisfaction can be influenced by momentary circumstances, and that awareness of these influences may strongly determine such evaluations, has implications for how, when and where accurate and reproducible measurements of life satisfaction should be obtained. For example, self-reports of life satisfaction (either formal or informal) from patients before and after a (often arduous) four-hour haemodialysis procedure may differ due to how the individual attributes their feelings following the treatment, and whether the patient is made explicitly aware of the affective stimulus. Numerous situations exist whereby other stimuli, when brought to consciousness, may influence the subjective reports of life satisfaction; these may in turn influence patients’ expectations, preferences, judgements and decisions. The field of ‘clinical decision-making’ has not taken these considerations into account historically, but rather focussed on how information is given to patients, and how questions and information are ‘framed’ [13]. We contend that consideration is required to consider the effect of bringing to salience experiences where affective information can be used to explain more durable life qualities and patient judgements. We believe the current study has demonstrated the former. The latter, we would argue, deserves more attention in the future. In essence, we propose that the affective component of information be considered as important as the rational and reasoned components in the realm of joint decision-making. On a similar note, consideration of the attributional style of the patient, and how they might ‘internalise’ information is worthy of recognition. As discussed above, the COVID-19 pandemic seems to have been ‘externally’ attributed by the population overall, but inter-individual variation is likely and should be considered [14].

We should again clarify that by virtue of the study methodology, the participants will have no ‘conscious’ access to the reasons for their reports. In other words, merely asking the COVID question does not make them consciously more satisfied with life or happier, as they have no ‘baseline’ state to compare against. Rather the purpose of the study was to demonstrate the ‘mood as information’ effect to caregivers and health providers, in a relevant ecological context, such that they are aware of unrecognised influences on patient reports. A logical next step is to now use this theory to test whether patient-level decisions on their health or behaviour are modified by such influences. We strongly suspect this will indeed be the case, but this contention requires formal testing.

The raw scores that the patients in this study reported were of significant interest to us. We fully recognise that detailed assessment of multiple domains of life satisfaction and happiness were not obtained, but that was not the purpose of the study. Indeed, we consider this would, in fact, have weakened our ability to draw robust conclusions due to multiple measurements. Despite this study investigating patients with an established chronic disease, shielding from a global pandemic, it is striking that the average responses across the four domains of questioning are very similar to those seen from the Schwarz and Clore study undertaken 4 decades ago on another continent with a very different cohort [3]. Although early data does point to a reduction in life satisfaction during the pandemic [10, 11], further inspection shows that this may not necessarily be universal. Von Soest, for example, investigated only adolescents [10]. Of the adult population studied by Zhang, a proportion displayed no reduction in life satisfaction; this latter group being characterised by individuals exercising less than 2.5 hours per day [11]. It is certainly the case that many of the transplant recipients investigated in the current study would fall into that relatively sedentary group, thus our raw results do resonate with the findings of Zhang. Finally, it is widely accepted that healthy people over-estimate the impact of disease on sufferers [15]. We must not be ignorant of challenges faced by some patients in this study, and by extrapolation others with chronic health conditions, but we should similarly resist the paternalistic temptation to create a blanket burden of distress where none exists.

The results of this study provide a unique insight into the life satisfaction of patients shielding during the COVID-19 pandemic, and whose experiences may differ from other people. We describe the relationship between momentary mood and more global life satisfaction in the highest risk patients in society, helping to understand the nature and consequences of these relationships. We hope this will inform practice and expectations in regard to patient care during the current pandemic; during future emergencies and when the ‘new normal’ eventually emerges.

Supporting information

S1 Data

(XLSX)

Acknowledgments

We would like to thank all patients for participating, and the members of staff in the renal department at the Queen Elizabeth Hospital for their efforts in supporting our work.

Data Availability

All relevant data are within the manuscript and Supporting Information files.

Funding Statement

This work was funded by the renal department at the Queen Elizabeth Hospital. This research was independent from external funders.

References

  • 1.National Institute for Health and Care Excellence. COVID-19 rapid guideline: renal transplantation. [internet]. June 2020 [accessed 01/07/2020]. Available from: https://www.nice.org.uk/news/article/nice-publishes-latest-covid-19-guidance-on-renal-transplantation [PubMed]
  • 2.Local Government Association. COVID-19, information for councils. [internet]. May 2020 [accessed https://www.local.gov.uk, May 2020 [accessed 23/06/2020].
  • 3.Schwarz N. Clore G. Mood, misattribution, and judgments of well-being: Informative and directive functions of affective states. Journal of Personality and Social Psychology 1983; 45(3): 513–523 [Google Scholar]
  • 4.Rutledge R. B., Skandali N., Dayan P., & Dolan R. J. A computational and neural model of momentary subjective well-being. Proceedings of the National Academy of Sciences of the United States of America 2014; 111(33): 12252–12257. 10.1073/pnas.1407535111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lucas RE, Lawless NM. Does life seem better on a sunny day? Examining the association between daily weather conditions and life satisfaction judgments. J Pers Soc Psychol 2013; 104(5): 872–884. 10.1037/a0032124 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Schwarz N. Clore G. Mood as Information. Psychology Inquiry 2003; 14(3): 296–303. [DOI] [Google Scholar]
  • 7.Strack F, Martin LL, Schwarz N. Priming and communication: Social determinants of information use in judgments of life satisfaction. European Journal of Social Psychology 1988; 18(5): 429–442. 10.1002/ejsp.2420180505 [DOI] [Google Scholar]
  • 8.Taylor SE. Assymetrical effects of positive and negative effects: the mobilisation-minimization hypothesis. Psychological Bulletin 1991. 110 (1): 67–85). 10.1037/0033-2909.110.1.67 [DOI] [PubMed] [Google Scholar]
  • 9.Diener E, Kanazawa S, Suh EM, Oishi S. Why People Are in a Generally Good Mood. Pers Soc Psychol Rev 2015; 19(3): 235–256. 10.1177/1088868314544467 [DOI] [PubMed] [Google Scholar]
  • 10.Von Soest T, Bakken A, Pedersen W, Sletten M. Life satisfaction among adolescents before and during the COVID-19 pandemic. Tidsskriftet for Den norske legeforening 2020. [DOI] [PubMed] [Google Scholar]
  • 11.Zhang SX, Wang Y, Rauch A, Wei F. Unprecedented disruption of lives and work: Health, distress, and life satisfaction of working adults in China one month into the COVID-19 outbreak. Psychiatry Res 2020; 288: 112958 10.1016/j.psychres.2020.112958 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Abramson LY, Seligman ME, & Teasdale JD. Learned helplessness in humans: Critique and reformulation. Journal of Abnormal Psychology 1978; 87(1): 49–74. 10.1037/0021-843X.87.1.49 [DOI] [PubMed] [Google Scholar]
  • 13.Gong J, Zhang Y, Feng J, et al. ‘Influence of framing on medical decision making’ EXCLI J 2013; 12: 20–29. [PMC free article] [PubMed] [Google Scholar]
  • 14.Steele C and Aronson J. Stereotype threat and intellectual test performance of African Americans. Journal of personality and social psychology 1995; 69 (3): 797–811. 10.1037//0022-3514.69.5.797 [DOI] [PubMed] [Google Scholar]
  • 15.Riis J, Loewenstein G, Baron J, et al. Ignorance of hedonic adaptation to hemodialysis: a study using ecological momentary assessment. J Exp Psychol Gen 2005; 134(1): 3–9. 10.1037/0096-3445.134.1.3 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Itamar Ashkenazi

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

21 Sep 2020

PONE-D-20-25329

Life Satisfaction and Happiness in Patients Shielding from the COVID-19 Global Pandemic: A Randomised controlled study of the ‘Mood as Information’ Theory

PLOS ONE

Dear Dr. O'Donnell,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The recommendations for changes are attached below.  As you will see these are minor.  Please submit your revised manuscript by Nov 05 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Itamar Ashkenazi

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Funding Section of your manuscript:

"This work was funded by the renal department at the Queen Elizabeth

Hospital. This research was independent from external funders."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"No. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Title: Life satisfaction and happiness in patients shielding from the COVID-19 Global Pandemic: A randomized controlled study of the ‘Mood as Information’ Theory

Study type: prospective randomized survey

Authors’ methodology and main results: The authors interviewed by telephone 200 kidney transplant patients shielding from COVID-19. They evaluated the effect of priming, as suggested by Schwarz and Clore’s study, on happiness and life satisfaction. Differences in happiness and satisfaction were noticed between those who were primed and those who were not.

Reviewer’s comments: I enjoyed reading this article. It asked a simple question and provided a simple answer. The discussion provides possible implications of priming on life satisfaction and happiness of our patients. I therefore recommend accepting this study for publication.

There are several minor issues that need to be addressed.

1. Results are repeated three times: within the text, in a table form and in a figure. This is unnecessary. I personally would prefer showing figure 1. The description within the text can then be shortened as follows:

A summary of the results of the 4 questions in the primed and no-primed groups can be seen in Figure 1. The answers to all questions across the groups were normally distributed. Differences observed between the two groups in overall happiness (t198=3.77; p=0.0002), desire to change (t198=3.78; p=0.0002), satisfaction with life as a whole (t198=3.93; p=0.0001) and happiness in this moment (t198=2.08; p=0.04) were all significant.

2. In figure 1, the authors provide the standard error. The authors should have drawn the standard deviation instead. Using the stars system with explanation provided just below the graph, the readers can understand which differences between columns were significant: * <0.05; ** <0.01; *** <0.001.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Dec 11;15(12):e0243278. doi: 10.1371/journal.pone.0243278.r002

Author response to Decision Letter 0


3 Nov 2020

Response to reviewers:

Dear Reviewers,

Thank you for your correspondence and for considering our study for publication. We are delighted that you agree our study holds merit and have provided us with such helpful comments. As a group we have met and discussed your comments in detail and worked through them in depth, hopefully addressing each point. We have revised the manuscript accordingly and would like to resubmit the revised version for your consideration. Below we have written our response to each of the comments provided.

Thank you again for your helpful comments and we look forward to hearing from you soon.

Journal requirements

Set 1:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Thank you for clarifying the style requirements PLOS ONE requires. In response to this comment we have altered the formatting to ensure that it complies with your requirements. We hope this satisfies your request.

2. Thank you for stating the following in the Funding Section of your manuscript:

"This work was funded by the renal department at the Queen Elizabeth

Hospital. This research was independent from external funders." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "No. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Thank you for this point. In reply to this, we have removed the funding statements from within the text. Please update our funding statement to the following: ‘This work was funded by the renal department at the Queen Elizabeth Hospital. This research was independent from external funders’. In addition, our cover letter now says: ‘This work was funded by the renal department at the Queen Elizabeth Hospital. This research was independent from external funders’.

We hope this is satisfactory and meets your request.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

Thank you very much for this comment. Due to ethical restrictions we are unable to share this de-identified data set, with our data containing sensitive patient information. This is inline with the CARMS (Clinical Audit & Registration management System) ethics committee at the Queen Elizabeth Hospital. The CARMS committee are in charge of organising the ethics that a project must follow, and set out that for this project we must not share de-identified patient data set, given the sensitive nature of this study. To contact the CARMS department at the Queen Elizabeth Hospital, you can email clinicalaudit@uhb.nhs.uk . We have included details of this in the cover letter, as requested. We are happy that all relevant data is within the manuscript we have resubmitted.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

Thank you for pointing this out and we fully appreciate this comment. In response to this, we believe it simpler to simply state the lack of difference in these parameters (as one would expect in a randomised study) rather than subsume the reader in unnecessary data, either in the article itself or supplementary. This was agreed between all authors to be the best approach, and we hope this meets with your approval. We have removed the phrase “data not shown” that relates to this data in response to your comment.

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

We thank you for clarifying this for us. We have now only included an ethical statement in the methods section of our paper.

Set 2

1. Results are repeated three times: within the text, in a table form and in a figure. This is unnecessary. I personally would prefer showing figure 1. The description within the text can then be shortened as follows:

A summary of the results of the 4 questions in the primed and no-primed groups can be seen in Figure 1. The answers to all questions across the groups were normally distributed. Differences observed between the two groups in overall happiness (t198=3.77; p=0.0002), desire to change (t198=3.78; p=0.0002), satisfaction with life as a whole (t198=3.93; p=0.0001) and happiness in this moment (t198=2.08; p=0.04) were all significant.

Thank you very much for this comment. We have replaced the summary of the results to comply with the above recommendation. Thank you again for this suggestion.

2. In figure 1, the authors provide the standard error. The authors should have drawn the standard deviation instead. Using the stars system with explanation provided just below the graph, the readers can understand which differences between columns were significant: * <0.05; ** <0.01; *** <0.001.

Thank you very much for this comment. Figure 1 has been changed to reflect the standard deviation rather than the standard error. This figure has replaced the previous figure and we hope you are happy with this change.

3. While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Thank you for notifying us about this tool, we have now uploaded the files to PACE.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Itamar Ashkenazi

19 Nov 2020

Life Satisfaction and Happiness in Patients Shielding from the COVID-19 Global Pandemic: A Randomised controlled study of the ‘Mood as Information’ Theory

PONE-D-20-25329R1

Dear Dr. O'Donnell,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Itamar Ashkenazi

Academic Editor

PLOS ONE

Acceptance letter

Itamar Ashkenazi

24 Nov 2020

PONE-D-20-25329R1

Life Satisfaction and Happiness in Patients Shielding from the COVID-19 Global Pandemic: A Randomised controlled study of the ‘Mood as Information’ Theory

Dear Dr. O'Donnell:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Itamar Ashkenazi

Academic Editor

PLOS ONE


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES